FASLG and Stevens-Johnson syndrome: Increased serum levels of soluble FAS-L, a mediator of the process of cell death (16), are a common feature in subjects with moderate and severe maculopapular exanthema without the development of bullous eruptions (i.e., Stevens-Johnson syndrome and toxic epidermal necrolysis) after benznidazole administration.